Provided by Tiger Trade Technology Pte. Ltd.

NeuroPace Inc.

13.33
-0.3300-2.42%
Post-market: 13.330.00000.00%16:10 EDT
Volume:249.66K
Turnover:3.36M
Market Cap:448.78M
PE:-20.32
High:13.68
Open:13.48
Low:13.17
Close:13.66
52wk High:18.98
52wk Low:7.56
Shares:33.67M
Float Shares:22.91M
Volume Ratio:1.05
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6560
EPS(LYR):-0.6560
ROE:-158.74%
ROA:-10.20%
PB:23.58
PE(LYR):-20.32

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials

Reuters
·
Nov 24, 2025

NeuroPace (NPCE) Gets a Buy from Lake Street

TIPRANKS
·
Nov 24, 2025

BUZZ-NeuroPace jumps as Medicare boosts pay for epilepsy device procedures

Reuters
·
Nov 24, 2025

NeuroPace Says Medicare Increases Reimbursement for RNS Procedures

MT Newswires Live
·
Nov 24, 2025

Neuropace Inc - Payment Rates Increased by Approximately 43% (+$530) for Initial Implant Procedure, 45% (+$260) for Replacement Procedure

THOMSON REUTERS
·
Nov 24, 2025

Neuropace Inc - Announces Favorable Medicare Reimbursement Increases

THOMSON REUTERS
·
Nov 24, 2025

3 Stocks Possibly Trading At A Discount Of Up To 37.8%

Simply Wall St.
·
Nov 21, 2025

NeuroPace Up Over 40%, On Pace for Record Percent Increase -- Data Talk

Dow Jones
·
Nov 06, 2025

NeuroPace Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05, 2025

J.P. Morgan Reaffirms Their Buy Rating on NeuroPace (NPCE)

TIPRANKS
·
Nov 05, 2025

Neuropace Shares up 19.9% Premarket After Q3 REV Beats Estimates

THOMSON REUTERS
·
Nov 05, 2025

NeuroPace Reports Record Revenue and Raises Guidance

TIPRANKS
·
Nov 05, 2025

NeuroPace reports Q3 EPS (11c), consensus (19c)

TIPRANKS
·
Nov 05, 2025

NeuroPace Q3 EPS $(0.11) Beats $(0.19) Estimate, Sales $27.354M Beat $24.634M Estimate

Benzinga
·
Nov 05, 2025

BRIEF-NeuroPace, Inc. Q3 EPS USD -0.11

Reuters
·
Nov 05, 2025

Neuropace, Inc. Q3 EPS USD -0.11

THOMSON REUTERS
·
Nov 05, 2025

Neuropace, Inc. Outlook FY Gross Margin 76-77%

THOMSON REUTERS
·
Nov 05, 2025

Press Release: NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Dow Jones
·
Nov 05, 2025

Neuropace Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025

Press Release: NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025

Dow Jones
·
Oct 22, 2025